SCHEMBL7107250

SCHEMBL7107250

COc1n[c]c2ccccc2c1-c1cnccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 4/20 0.35
PIM1 P11309 2/20 0.34
MAPT P10636 4/20 0.33
CASP1 P29466 1/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
NR4A1 P22736 1/20 0.33
ESR2 Q92731 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
AURKA O14965 1/20 0.33
TTK P33981 1/20 0.33
AURKB Q96GD4 1/20 0.33
INCENP Q9NQS7 1/20 0.33
CYP2C9 P11712 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7447549 0.85 MAPT (0.43) RECQLHTTALDH1A1CYP2C19CYP1A2
SCHEMBL7111069 0.80 ALDH1A1 (0.39) RECQLHTTALDH1A1CYP2C19CYP1A2
SCHEMBL7110679 0.74 PDPK1 (0.38) RECQLALDH1A1CYP2C19CYP1A2
SCHEMBL7112453 0.74 CYP3A4 (0.39) RECQLHTTALDH1A1CYP2C19CYP1A2
SCHEMBL7111035 0.74 BRD4 (0.37) ALDH1A1CYP2C19CYP1A2MAPT
SCHEMBL9218409 0.71 ALDH1A1 (0.45) ALDH1A1CYP2C19CYP1A2MAPTCASP1
SCHEMBL638668 0.71 ALDH1A1 (0.45) ALDH1A1CYP2C19CYP1A2CYP3A4MAPT
SCHEMBL6490955 0.70 DUSP4 (0.42) ALDH1A1CYP2C19CYP1A2CYP3A4MAPT
SCHEMBL637848 0.69 ALDH1A1 (0.44) ALDH1A1CYP2C19CYP1A2MAPTCASP1
SCHEMBL8273102 0.69 BTK (0.49) RECQLHTTALDH1A1CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MCCLURE KIM F (US) 2003-01-09 US disclosed
EP-1104403-A1 HYDROXY PIPECOLATE HYDROXAMIC ACID DERIVATIVES AS MMP INHIBITORS Pfizer Products Inc. (US) 2001-06-06 EP disclosed
WO-2000009485-A1 HYDROXY PIPECOLATE HYDROXAMIC ACID DERIVATIVES AS MMP INHIBITORS PFIZER PRODUCTS INC. (US) 2000-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MMP1, MMP10, MMP3 RECQL 459/4885HTT 102/4885ALDH1A1 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.